The Zhitong Finance App learned that Keji Pharmaceutical-B (02171.HK) rose more than 4% after the results. As of press release, it had risen 4.08% to HK$15.31, with a turnover of HK$12.5726 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.